Myriad Genetics Inc (MYGN)

Net profit margin

		Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Jun 30, 2020	Jun 30, 2019
Net income	US$ in thousands	-263,300	-112,000	-27,200	-199,500	4,600
Revenue	US$ in thousands	745,400	675,200	846,000	627,800	840,000
Net profit margin		-35.32%	-16.59%	-3.22%	-31.78%	0.55%

December 31, 2023 calculation

Net profit margin = Net income ÷ Revenue
= $-263,300K ÷ $745,400K
= -35.32%

The net profit margin of Myriad Genetics, Inc. has fluctuated significantly over the past five periods. The company experienced negative net profit margins in four out of the five periods, indicating that its expenses have exceeded its revenue during those times. The most recent net profit margin of -34.96% as of December 31, 2023, reflects a substantial decrease compared to the previous periods. This suggests that the company's profitability has deteriorated significantly.

The net profit margin of -16.51% as of December 31, 2022, and -3.94% as of December 31, 2021, also show negative profitability, although the extent of the losses appears to have lessened compared to the latest period. The net profit margin of -31.24% as of June 30, 2020, was notably high, indicating significant losses relative to revenue at that time. In contrast, the June 30, 2019, net profit margin of 0.54% was positive, indicating a small level of profitability.

Overall, the trend in Myriad Genetics' net profit margin suggests the company has struggled to maintain profitability in recent years, with the most recent period showing a significant decline. This may raise concerns about the company's cost management, revenue generation, and overall financial health.